| [1] |
Wan QC, Rong SZ, Peter D, et al. Cancer statistics in China, 2015[J]. Ca-Cancer J Clin, 2016, 66(2): 115-132.
|
| [2] |
周星彤，沈松杰，孙强．中国乳腺癌筛查现状及进展[J/CD]．中国医学前沿杂志(电子版)，2020，12(3): 6-11.
|
| [3] |
Torre LA, Siegel RL, Jemal A, et al. Lung cancer statistics[J]. Adv Exp Med Biol, 2016, 893: 1-19.
|
| [4] |
Pere G, Andres C, Vicente A, et al. Management of cirrhosis and ascites[J]. New Engl J Med, 2004, 350(16): 300-301.
|
| [5] |
魏静，王石健．黄腐醇对SH-SY5Y细胞氧化应激损伤的保护机制研究[J]．中国药师，2020，23(7)：1279-1283.
|
| [6] |
Zhang YM, Shi XB, Xu B, et al. Endoplasmic reticulum stress mediated the xanthohumol induced murine melanoma B16-F10 cell death[J]. J Asian Nat Prod Res, 2020, 22(9): 850-863.
|
| [7] |
张坚红，谢元康，胡泽明，等．黄腐酚对胆管癌QBC939细胞生长和凋亡的影响及其机制研究[J]．赣南医学院学报，2020, 40(4): 358-361.
|
| [8] |
Bogdanov A, Katerin A, Roderov A, et al. Antibiofilm activity of bioactive hop compounds humulone, lupulone and xanthohumol toward susceptible and resistant staphylococci[J]. Res Microbiol, 2018, 169(3)：127-134.
|
| [9] |
Jiang W, Zhao S, Xu L, et al. The inhibitory effects of xanthohumol, a prenylated chalcone derived from hops, on cell growth and tumorigenesis in human pancreatic cancer[J]. Biomed Pharmacother, 2015, 73: 40-47.
|
| [10] |
Marchand LL. Cancer preventive effects of flavonoids—a review[J]. Biomed Pharmacother, 2002, 56(6): 296-301.
|
| [11] |
Miranda CL, Stevens JF, Helmrich A, et al. Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines[J]. Food Chem Toxicol, 1999, 37(4): 271-285.
|
| [12] |
Tomasz T, Agnieszka B, Beata FP, et al. Fungal metabolites of xanthohumol with potent antiproliferative activity on human cancer cell lines in vitro[J]. Bioorgan Med Chem, 2013, 21(7): 2001-2006.
|
| [13] |
Agnieszka B, Tomasz T, Jarosaw P, et al. Highly cancer selective antiproliferative activity of natural prenylated flavonoids[J]. Molecules, 2018, 23(11): 2922.
|
| [14] |
Barbara G, Marta A, Adrianna SB, et al. Prostate and breast cancer cells death induced by xanthohumol investigated with Fourier transform infrared spectroscopy[J]. Spectrochim Acta A, 2020, 231: 1181-1200.
|
| [15] |
Young KS, Ik-Soo L, Aree M. 2-Hydroxychalcone and xanthohumol inhibit invasion of triple negative breast cancer cells[J]. Chem-Biol Interact, 2013, 203(3): 565-572.
|
| [16] |
Mar BR, Jordi O, Adamo V, et al. Effect of xanthohumol and 8-prenylnaringenin on MCF-7 breast cancer cells oxidative stress and mitochondrial complexes expression[J]. J Cell Biochem, 2013, 114(12): 2785-2794.
|
| [17] |
Ottewell PD, Donnell L, Holen I, et al. Molecular alterations that drive breast cancer metastasis to bone[J]. Bonekey Rep, 2015, 4: 643.
|
| [18] |
Wang Y, Chen Y, Wang J, et al. Xanthohumol, a prenylated chalcone derived from hops, suppresses cancer cell invasion through inhibiting the expression of CXCR4 chemokine receptor[J]. Curr Mol Med, 2012, 12(2): 153-162.
|
| [19] |
Vanhoecke B, Derycke L, Van Marck V, et al. Antiinvasive effect of xanthohumol, a prenylated chalcone present in hops (Humulus lupulus L．) and beer[J]. Int J Cancer, 2005, 117(6): 889-895.
|
| [20] |
Croce CM, Reed JC. Reed J. Finally, an apoptosis-targeting therapeutic for cancer[J]. Cancer Res, 2016, 76(20): 5914-5920.
|
| [21] |
刘惠娟，包勇，杨永华．黄酮类化合物的抗肿瘤作用[J]．中国药理学与毒理学杂志，2016，30(10): 1060.
|
| [22] |
刘超，邓智勇．肺癌多药耐药机制及其逆转方法的研究进展[J]．标记免疫分析与临床，2016, 23(9)：1086-1090.
|
| [23] |
Liu M, Yin H, Qian X, et al. Xanthohumol, a prenylated chalcone from hops, inhibits the viability and stemness of doxorubicin-resistant MCF-7/ADR Cells[J]. Molecules, 2016, 22(1): 36.
|
| [24] |
李晨龙，李海宁，郭红云，等．黄腐酚诱导非小细胞肺癌细胞凋亡的初步研究[J]．解放军药学学报，2017，33(2)：109-112.
|
| [25] |
Roehrer S, Stork V, Ludwig C, et al. Analyzing bioactive effects of the minor hop compound xanthohumol C on human breast cancer cells using quantitative proteomics[J]. PLoS One, 2019, 14(3): e0 213 469.
|
| [26] |
Kim SY, Lee IS, Moon A. 2-Hydroxychalcone and xanthohumol inhibit invasion of triple negative breast cancer cells[J]. Chem-Biol Interact, 2013, 203(3): 565-572.
|
| [27] |
Yoo YB, Park KS, Kim JB, et al. Xanthohumol inhibits cellular proliferation in a breast cancer cell line (MDA-MB 231) through an intrinsic mitochondrial-dependent pathway[J]. Indian J Cancer, 2014, 51(4)：518-523.
|
| [28] |
Dowsett M, Nielsen TO, Ahern R, et al. Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in breast cancer working group[J]. J Natl Cancer Inst, 2011, 103(22): 1656-1664.
|
| [29] |
Gabos Z, Thoms J, Ghosh S, et al. The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer[J]. Breast Cancer Res Treat, 2010, 124(1): 187-194.
|
| [30] |
Shapiro , Geoffrey I. Cyclin-dependent kinase pathways as targets for cancer treatment[J]. J Clin Oncol, 2006, 24(11): 1770-1783.
|
| [31] |
Sun ZH, Zhou C, Liu F，et al. Inhibition of breast cancer cell survival by xanthohumol via modulation of the Notch signaling pathway in vivo and in vitro[J]. Oncol Lett, 2018, 15(1)：908-916.
|
| [32] |
闫成．乳腺癌免疫治疗研究进展[J]．中国城乡企业卫生，2021，36(5)：81-83.
|
| [33] |
Zhang W, Pan Y, Gou P, et al. Effect of xanthohumol on Th1/Th2 balance in a breast cancer mouse model[J]. Oncol Rep, 2018, 39(1): 280-288.
|
| [34] |
王羽，陈晰，柳林，等．激素受体阳性的绝经后乳腺癌芳香化酶抑制剂辅助治疗的时长[J]．临床外科杂志，2018，26(6)：474-477.
|
| [35] |
高亚琳，杨逸雨，李靖若．晚期乳腺癌内分泌治疗现状及展望[J/CD]．中华乳腺病杂志(电子版), 2016，10(1)：54-56.
|
| [36] |
Monteiro R, Faria A, Azevedo I, et al. Modulation of breast cancer cell survival by aromatase inhibiting hop (Humulus lupulus L．) flavonoids[J]. J Steroid Biochem Mol Biol, 2007, 105(1-5): 124-130.
|
| [37] |
Cassidy CE, William NS. Cancer-relevant biochemical targets of cytotoxic Lonchocarpus flavonoids: a molecular docking analysis[J]. J Mol Model, 2010, 16(2): 311-326.
|
| [38] |
Rosario M, Hans B, Isabel A, et al. Effect of hop (Humulus lupulus L．) flavonoids on aromatase (estrogen synthase) activity[J]. J Agr Food Chem, 2006, 54(8): 2938-2943.
|
| [39] |
Chen XS, Ma CD, Wu JY, et al. Molecular subtype approximated by quantitative estrogen receptor, progesterone receptor and HER2 can predict the prognosis of breast cancer[J]. Tumori, 2010, 96(1): 103-110.
|
| [40] |
Yoshimaru T, Komatsu M, Tashiro E, et al. Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions[J]. Sci Rep, 2014, 4: 7355.
|
| [41] |
Hemachandra LP, Madhubhani P, Chandrasena R, et al. Hops (Humulus lupulus) inhibits oxidative estrogen metabolism and estrogen-induced malignant transformation in human mammary epithelial cells (MCF-10A)[J]. Cancer Prev Res (Phila), 2012, 5(1): 73-81.
|
| [42] |
Nalo H, Diana MG, Vei M, et al. Biologic roles of estrogen receptor-β and insulin-like growth factor-2 in triple-negative breast cancer[J]. Biomed Res Int, 2015, 2015: 925 703.
|
| [43] |
Guerreiro S, Monteiro R, Martins MJ, et al. Distinct modulation of alkaline phosphatase isoenzymes by 17beta-estradiol and xanthohumol in breast cancer MCF-7 cells[J]. Clin Biochem, 2007, 40(3-4): 268-273.
|
| [44] |
Rosario M,，Conceicao C, Susana G, et al. Xanthohumol inhibits inflammatory factor production and angiogenesis in breast cancer xenografts[J]. J Cell Biochem, 2010, 104(5): 1699-1707.
|
| [45] |
Wyns C, Steendam KV, Vanhoecke B, et al. Prenylated chalcone xanthohumol associates with histones in breast cancer cells-a novel target identified by a monoclonal antibody[J]. Mol Nutr Food Res, 2012, 56(11): 1688-1696.
|